Skip to content
naulon
Not checkedNot checked for notices yet.

Left Ventricular Thrombus With COVID-19 Complication in a Patient With Dilated CardiomyopathyNovel Teaching Points

Shohei Imaeda, MD, Hiroki Kabata, MD, PhD, Yasuyuki Shiraishi, MD, PhD and 6 more

CJC Open · 2021

doi:10.1016/j.cjco.2020.09.014 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Thrombosis, especially venous thromboembolism, is a complication often associated with coronavirus disease 2019 (COVID-19). However, there have been relatively few reports of arterial thrombosis. Here, we describe a case of non-severe COVID-19 in a patient with dilated cardiomyopathy. After admission, symptoms, laboratory data, and imaging findings improved, but D-dimer levels gradually increased. Contrast computed tomography and echocardiography revealed a left ventricular thrombus. Anticoagulant treatment diminished the thrombus, and the patient recovered and was discharged. Although a left ventricular thrombus is a rare COVID-19 complication, performing appropriate diagnostic tests could improve COVID-19 mortality in patients with dilated cardiomyopathy. Résumé: La thrombose, en particulier la maladie thromboembolique veineuse, est une complication souvent associée à la maladie à coronavirus 2019 (COVID-19). Cependant, il y a eu relativement peu de cas rapportés de thrombose artérielle. Nous décrivons ici un cas non grave de COVID-19 chez un patient atteint de cardiomyopathie dilatée. Après admission, des améliorations ont été constatées concernant les symptômes, les résultats des tests de laboratoire et les résultats d'imagerie, mais les taux de D-dimères ont progressivement augmenté. La tomodensitométrie avec produit de contraste et l'échocardiographie ont révélé un thrombus ventriculaire gauche. Un traitement anticoagulant a réduit le thrombus, et le patient s'est remis et a reçu son congé. Bien qu'un thrombus ventriculaire gauche soit une complication rare de la COVID-19, la réalisation de tests diagnostiques appropriés pourrait diminuer la mortalité due à la COVID-19 chez les patients atteints de cardiomyopathie dilatée.

Abstract licence: CC BY-NC-ND

References5

    5 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.